The Lowdown - An AI-based medical device that uniquely combines clinical guidance with real user experience to support improved contraceptive understanding and use.

The Lowdown - 一种基于人工智能的医疗设备，将临床指导与真实用户体验独特地结合起来，以支持提高避孕药具的理解和使用。

• 批准号: 10103064
• 金额: $ 48.36万
• 依托单位: GET THE LOWDOWN LTD
• 依托单位国家: 英国
• 项目类别: Collaborative R&D
• 财政年份: 2024
• 资助国家: 英国
• 起止时间: 2024 至 无数据
• 项目状态: 未结题
• 来源: https://gtr.ukri.org/projects?ref=10103064
• 关键词: Lowdown; AI; based; medical; device

With the combined support of Innovate-UK and investment finance, Get The Lowdown Ltd (GTLD) will develop the first dedicated and clinically validated platform that combines the latest clinical guidance with real user experience to provide tailored contraceptive advice specific to the user across all forms of contraception and in doing so reducing the need for an appointment with a healthcare professional to address commonly asked questions. The concept has been designed to address key challenges in accessing support in this complex area of healthcare and known gaps in knowledge in Primary and Secondary Care with information given in an easy-to-understand format aimed at all target users regardless of ethnicity/culture, age, gender and level of health literacy. Combined grant and investor funding will accelerate development and exploitation in the global FemTech market, forecast to reach $5.0Bn by 2033 and support future application across wider health conditions including fertility, polycystic ovary syndrome and endometriosis.

在Innovate-UK和投资融资的共同支持下，Get The Lowdown Ltd(GTLD)将开发第一个经过临床验证的专用平台，将最新的临床指导与真实的用户体验相结合，为所有形式的避孕措施的用户提供量身定制的避孕建议，从而减少与医疗保健专业人员预约解决常见问题的需要。这一概念旨在解决在这一复杂的医疗保健领域获得支持的关键挑战，以及初级和二级保健知识方面的已知差距，以一种易于理解的格式向所有目标用户提供信息，而不考虑种族/文化、年龄、性别和健康素养水平。赠款和投资者资金的结合将加快全球FemTech市场的开发和开发，预计到2033年，全球FemTech市场将达到50亿美元，并支持未来在更广泛的健康状况下的应用，包括生育、多囊卵巢综合征和子宫内膜异位症。